Iconic Labs PLC Results of Creditors and General Meetings (3711A)
22 Septembre 2022 - 06:59PM
UK Regulatory
TIDMICON
RNS Number : 3711A
Iconic Labs PLC
22 September 2022
Iconic Labs PLC
22 September 2022
Iconic Labs Plc - In Administration ("Iconic Labs" or the
"Company")
Notice of Results of Creditors Meeting and General Meeting of
Shareholders
Iconic Labs Plc (LSE:ICON hereby advises that it held a general
meeting ("GM") earlier today.
The CVA Proposal was approved by the requisite majorities of the
creditors at a meeting of the creditors held today at 11am.
At a meeting of the shareholders of the Company, held today at
2.00pm, all resolutions were duly passed on a poll vote.
Details of the proxy voting are shown in the table below.
Votes % Votes % Votes Total Votes Withheld
For Against
Ordinary resolutions:
---------------- ------- --------------- ------ ---------------- --------------
(1) Approval of the Company
Voluntary Arrangement ("CVA")
. 10,009,834,608 97.49 257,331,813 2.51 10,267,166,421 48,068,796
---------------- ------- --------------- ------ ---------------- --------------
(2) To empower the directors
to generally allot relevant
equity securities in respect
of the CVA 10,240,735,765 99.74 26,430,656 0.26 10,267,166,421 48,068,796
---------------- ------- --------------- ------ ---------------- --------------
(3) To empower the directors
to generally allot relevant
equity securities to promote
the success of the Company 10,240,225,765 99.74 26,430,656 0.26 10,266,656,421 48,578,796
---------------- ------- --------------- ------ ---------------- --------------
Special resolutions:
---------------- ------- --------------- ------ ---------------- --------------
(4) Subject to the passing
of Resolution 2, to disapply
the pre-emptive rights in
respect of the relevant
equity securities to be
allotted in respect of CVA
Proposal . 10,009,324,608 97.49 257,331,813 2.51 10,266,656,421 48,578,796
---------------- ------- --------------- ------ ---------------- --------------
(5) Subject to the passing
of Resolution 3, to disapply
the pre-emptive rights in
respect of the relevant
equity securities to be
allotted to promote the
success of the Company. 10,240,225,765 99.74 26,430,656 0.26 10,266,656,421 48,578,796
---------------- ------- --------------- ------ ---------------- --------------
The full text of each of the resolutions is set out in the
Notice of AGM, available on the Company's website
(www.iconiclabs.co.uk).
Market Abuse Regulation (MAR) Disclosure - Certain information
contained in this announcement would have been deemed inside
information for the purposes of Article 7 of Regulation (EU) No
596/2014 until the release of this announcement.
For further information, please visit the Company's website
www.iconiclabs.co.uk or contact the Company via ir@iconiclabs.co.uk
.
END
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMBLGDCRSDDGDD
(END) Dow Jones Newswires
September 22, 2022 12:59 ET (16:59 GMT)
Widecells (LSE:WDC)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Widecells (LSE:WDC)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024